UTMD (Utah Medical Products Inc) Stock Analysis - Politician Trades
Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded UTMD stock?
Rallies tracks politician and congressional stock disclosures for UTMD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.
UTMD Analyst Consensus
UTMD analyst coverage data. Average price target: $0.00.
Common questions about UTMD
Which politicians traded UTMD stock?
Rallies tracks politician and congressional stock disclosures for UTMD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in UTMD?
Yes. Rallies tracks politician and congressional stock disclosures for UTMD, including reported purchases, sales, dates, owners, and trade amounts when available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
